AEterna Zentaris Inc (AEZS.O)

AEZS.O on Consolidated Issue listed on NASDAQ Capital Market

1.45USD
2 Sep 2014
Price Change (% chg)

$-0.05 (-3.33%)
Prev Close
$1.50
Open
$1.54
Day's High
$1.54
Day's Low
$1.37
Volume
3,319,651
Avg. Vol
866,613
52-wk High
$1.75
52-wk Low
$0.99

AEZS.O

Chart for AEZS.O

About

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company’s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. The development priorities in oncology are the completion of Phase 3 trials with perifosine in... (more)

Overall

Beta: 1.55
Market Cap (Mil.): $85.82
Shares Outstanding (Mil.): 57.89
Dividend: --
Yield (%): --

Financials

  AEZS.O Industry Sector
P/E (TTM): -- 155.71 33.55
EPS (TTM): -0.90 -- --
ROI: -64.08 -3.31 17.24
ROE: -522.17 -7.86 18.05
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks